Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 218
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02882893 | Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines | ||
| NCT02415777 | Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction | ||
| NCT03574415 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean | ||
| NCT04772443 | Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 | ||
| NCT05465668 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C | ||
| NCT04524052 | To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 | ||
| NCT05747664 | To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function | ||
| NCT06866509 | To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients | ||
| NCT06272630 | Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease | ||
| NCT05376969 | Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin | ||
| NCT07267221 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition. | ||
| NCT05389215 | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF | ||
| NCT05083299 | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate | ||
| NCT05812404 | Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects | ||
| NCT02757144 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers | ||
| NCT05614752 | Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT04294251 | Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT01634308 | Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation | ||
| NCT05149274 | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects | ||
| NCT03846453 | A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes | ||
| NCT03517319 | Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity | ||
| NCT06062030 | Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy; | ||
| NCT06592495 | Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 | ||
| NCT05607589 | The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects | ||
| NCT02241850 | Genetic Polymorphisms Affecting Effect of High Intensity Training | ||
| NCT05643508 | A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia | ||
| NCT04014023 | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT04221399 | Type 2 Diabetes Patients With Renal Impairment | ||
| NCT04782505 | Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers | ||
| NCT04328766 | Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers | ||
| NCT05574374 | Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects | ||
| NCT01423526 | A Single Dose Study of DWP10292 in Healthy Male Subjects | ||
| NCT02385032 | Comparative Bioavailability Study of UDCA | ||
| NCT07260851 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions | ||
| NCT05614765 | Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment | ||
| NCT02332044 | Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers | ||
| NCT02665832 | Study of DWJ1351 in Healthy Male Volunteers | ||
| NCT06508645 | Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers | ||
| NCT03736369 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | ||
| NCT05226533 | Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients. | ||
| NCT05993247 | Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients | ||
| NCT05737771 | To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination | ||
| NCT05378360 | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT05699070 | Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects | ||
| NCT01654640 | The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine | ||
| NCT04888819 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT04341428 | Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis | ||
| NCT04888728 | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers |
